Joan Carles Reverter

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

Joan Carles Reverter, H. Kessels, Raman Kumar et al. · Journal of Clinical Investigation · 1996 · 397 citations · Full text

Immunology, Immunotherapy, Inflammation +20

Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial

Faustino Torrico, Joaquím Gascón, Lourdes Ortiz et al. · The Lancet Infectious Diseases · 2018 · 292 citations · Full text

Pharmacology, Gastroenterology, Placebo-controlled Trial +2

Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status.

Eduardo Arellano‐Rodrigo, Alberto Álvarez‐Larrán, Joan Carles Reverter et al. · PubMed · 2006 · 275 citations

TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy

Antonia Perelló, Juan Carlos García‐Pagán, Rosa Gilabert et al. · Hepatology · 2002 · 217 citations

Bone Marrow Changes in Anorexia Nervosa Are Correlated With the Amount of Weight Loss and Not With Other Clinical Findings

Eugènia Abella, Evarist Feliú, Isabel Granada et al. · American Journal of Clinical Pathology · 2002 · 204 citations · Full text

Nutrition, Bone Marrow Changes, Metabolic Disorder +22